Clinical Research Directory
Browse clinical research sites, groups, and studies.
New Treatment for Nocturnal Enuresis in Children
Sponsor: Sohag University
Summary
The aim of the study is to evaluate the role of sulbutiamine in treatment of monosymptomatic nocturnal enuresis in children by using it alone or as a combination therapy with tricyclic antidepressants (imipramine+sulbutiamine).
Official title: Outcome of Treatment of Monosymptomatic Nocturnal Enuresis in Children Using Imipramine Alone Versus Sulbutiamine Alone Versus Imipramine Plus Sulbutiamine : Prospective Comparative Study
Key Details
Gender
All
Age Range
6 Years - 18 Years
Study Type
INTERVENTIONAL
Enrollment
450
Start Date
2024-03-01
Completion Date
2024-11
Last Updated
2024-07-12
Healthy Volunteers
Yes
Conditions
Interventions
Sulbutiamine
sulbutiamine will be used by oral route 100 mg daily for 1 month and follow up will be done every 1 month till 3 months. it will be used alone in group B and combined with imipramine in group C
Imipramine
imipramine will be used by oral route 25 mg daily for 1 month and follow up will be done every 1 month till 3 months. it will be used alone in group A and combined with sulbutiamine in group C
Locations (1)
Sohag Faculty of Medecine
Sohag, Egypt